This country profile provides an overview of the Congo’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
14%
Blinding trachoma
N/A
Intestinal worms
38%
Bilharzia
53%
River blindness
29%
0.83 million people received treatment in the Congo in 2017 0.95 million people did not receive treatment in the Congo in 2017

Priorities for progress in Congo

  • Congo is encouraged to continue working to build its national preventive chemotherapy programme for NTDs.
  • It should aim to provide a systematically high annual coverage of all intervention components, in all risk groups, as recommended by WHO.
  • Further, Congo should carry out mapping for the elimination of river blindness.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage increased from 12% in 2016 to 14% in 2017.

People needing treatment
0.77m
People receiving treatment
0.11m

Blinding trachoma

Congo does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage increased 3% in 2016 to 38% in 2017.

Pre-sch and school-aged children needing treatment
0.71m
Pre-school and school-aged children receiving treatment
0.27m

Schistosomiasis

Treatment coverage increased from 25% in 2016 to 53% in 2017.

School-aged children needing treatment
0.14m
School-aged children receiving treatment
0.07m

River blindness

Treatment coverage decreased from 79% in 2016 to 29% in 2017.

People needing treatment
1.67m
People receiving treatment
0.49m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Congo.